Skip to main content

Resting Metabolic Rate

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Clarity Pharmaceuticals
Clarity PharmaceuticalsAustralia - Eveleigh
1 program
IGNITE PatchN/A1 trial
Active Trials
NCT07781384Enrolling By Invitation150Est. Nov 2026
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Indirect CalorimetryN/A1 trial
Active Trials
NCT04478565Completed15Est. Jun 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Clarity PharmaceuticalsIGNITE Patch
Human BioSciencesIndirect Calorimetry

Clinical Trials (2)

Total enrollment: 165 patients across 2 trials

Observing Performance of Haptic Vibrotactile Trigger Technology by Measuring Changes in Resting Metabolic Rate: Assessment and Analysis

Start: Jun 2023Est. completion: Nov 2026150 patients
N/AEnrolling By Invitation
NCT04478565Human BioSciencesIndirect Calorimetry

Development of Alternatives for the Estimation of the Resting Metabolic Rate From Anthropometry in Paralympic Athletes

Start: Jun 2016Est. completion: Jun 201615 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.